Ingevity Corp

2026-02-23 21:45:10

Ingevity Corporation announced that its board will shrink from 11 to 9 members as two founding directors, Daniel F. Sansone and Jean S. Blackwell, will not seek re-election. This change is part of normal board refreshment and portfolio optimization efforts. The company's shares have delivered a 57% return over the past year and are considered undervalued by InvestingPro analysis.

2026-02-23 20:45:10

Ingevity Corporation (NYSE: NGVT) announced that two founding directors, Daniel F. Sansone and Jean S. Blackwell, will not seek re-election at the company's 2026 Annual Meeting. Sansone is retiring due to the board's mandatory age policy, and Blackwell is concluding her tenure after ten years of service. Following these transitions, Ingevity's board will be resized from 11 to 9 members, aligning with the company's strategic direction and portfolio optimization efforts.

2026-02-14 21:05:00

This article previews INGEVITY's (NGVT) Q4 2025 earnings, expected February 16th, with analysts projecting $262.4 million in revenue and $0.70 EPS. It details recent hedge fund activity, noting that while 119 institutional investors added NGVT shares, 150 decreased their positions. The article also provides recent analyst price targets for NGVT, with a median target of $67.5.

2026-02-12 16:27:25

The U.S. Court of Appeals for the Federal Circuit has upheld an $85 million antitrust verdict against Ingevity Corp., affirming a Delaware jury's finding that the company illegally tied patent licenses to purchases of its unpatented carbon filtering products. The court rejected Ingevity's defense that its products were "nonstaple" goods, as evidence showed they had substantial non-infringing uses. This decision leaves the trebled damages award intact and stems from BASF Corp.'s antitrust counterclaims against Ingevity.

2026-02-12 07:27:51

The Federal Circuit has upheld an $85 million antitrust verdict against Ingevity Corp., ruling that the company engaged in anticompetitive tying by linking licenses for its auto carbon filtering technology to purchases of unpatented products. The court rejected Ingevity's patent misuse defense, finding that the tied products, carbon filtering honeycombs, were staple goods with significant non-infringing uses. This decision reinforces limits on the patent misuse defense in antitrust disputes, especially when tying patent licensing to products with multiple uses.

2026-02-11 18:31:00

A US appeals court affirmed an $85 million antitrust verdict in favor of BASF against Ingevity Corp. The court found substantial evidence supported the jury's conclusion that Ingevity’s honeycombs were staple goods and its patent misuse-based defense failed. It also ruled that Ingevity's attempt to argue distinct tying conduct immunity on appeal was too late.